Spotlight on PSMA as a new theranostic biomarker for bladder cancer
Abstract Bladder cancer (BCa) patients are diagnosed by cytology and cystoscopy. However, these diagnostic tests bear some limitations. We sought for reliable biomarkers to better determine BCa extension. Prostate-specific membrane antigen (PSMA) appears to fulfill this requirement in prostate cance...
Enregistré dans:
Auteurs principaux: | Maria Maddalena Tumedei, Sara Ravaioli, Federica Matteucci, Monica Celli, Ugo De Giorgi, Roberta Gunelli, Maurizio Puccetti, Giovanni Paganelli, Sara Bravaccini |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/9e48e4bb4424421c8efc0070bd91a8d6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
PSMA expression by microvasculature of thyroid tumors – Potential implications for PSMA theranostics
par: Andrey Bychkov, et autres
Publié: (2017) -
The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects
par: Sara Bravaccini, et autres
Publié: (2021) -
PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook
par: Maximilian A. Kirchner, et autres
Publié: (2021) -
Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer
par: Kristin A. Plichta, et autres
Publié: (2021) -
Potential Targets Other Than PSMA for Prostate Cancer Theranostics: A Systematic Review
par: Mathieu Gauthé, et autres
Publié: (2021)